<VariationArchive VariationID="3254903" VariationName="NM_015559.3(SETBP1):c.1119del (p.Ala374fs)" VariationType="Deletion" Accession="VCV003254903" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2024-07-23" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3413677" VariationID="3254903">
      <GeneList>
        <Gene Symbol="SETBP1" FullName="SET binding protein 1" GeneID="26040" HGNC_ID="HGNC:15573" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>18q12.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="44680073" stop="45068510" display_start="44680073" display_stop="45068510" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="42260137" stop="42648474" display_start="42260137" display_stop="42648474" Strand="+" />
          </Location>
          <OMIM>611060</OMIM>
          <Haploinsufficiency last_evaluated="2018-05-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SETBP1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-05-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SETBP1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_015559.3(SETBP1):c.1119del (p.Ala374fs)</Name>
      <CanonicalSPDI>NC_000018.10:44950457:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>18q12.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="44950458" stop="44950458" display_start="44950458" display_stop="44950458" variantLength="1" positionVCF="44950457" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="42530423" stop="42530423" display_start="42530423" display_stop="42530423" variantLength="1" positionVCF="42530422" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>A374fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.10" sequenceAccession="NC_000018" sequenceVersion="10" change="g.44950459del" Assembly="GRCh38">
            <Expression>NC_000018.10:g.44950459del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.9" sequenceAccession="NC_000018" sequenceVersion="9" change="g.42530424del" Assembly="GRCh37">
            <Expression>NC_000018.9:g.42530424del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_027527.2" sequenceAccession="NG_027527" sequenceVersion="2" change="g.275287del">
            <Expression>NG_027527.2:g.275287del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001379141.1" sequenceAccession="NM_001379141" sequenceVersion="1" change="c.1119del">
            <Expression>NM_001379141.1:c.1119del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001366070.1" sequenceAccession="NP_001366070" sequenceVersion="1" change="p.Ala374fs">
            <Expression>NP_001366070.1:p.Ala374fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001379142.1" sequenceAccession="NM_001379142" sequenceVersion="1" change="c.1119del">
            <Expression>NM_001379142.1:c.1119del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001366071.1" sequenceAccession="NP_001366071" sequenceVersion="1" change="p.Ala374fs">
            <Expression>NP_001366071.1:p.Ala374fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001410862.1" sequenceAccession="NM_001410862" sequenceVersion="1" change="c.1119del">
            <Expression>NM_001410862.1:c.1119del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001397791.1" sequenceAccession="NP_001397791" sequenceVersion="1" change="p.Ala374fs">
            <Expression>NP_001397791.1:p.Ala374fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015559.3" sequenceAccession="NM_015559" sequenceVersion="3" change="c.1119del" MANESelect="true">
            <Expression>NM_015559.3:c.1119del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_056374.2" sequenceAccession="NP_056374" sequenceVersion="2" change="p.Ala374fs">
            <Expression>NP_056374.2:p.Ala374fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015559.3" sequenceAccession="NM_015559" sequenceVersion="3" change="c.1119delC" MANESelect="true">
            <Expression>NM_015559.3:c.1119delC</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1150" sequenceAccession="LRG_1150">
            <Expression>LRG_1150:g.275287del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1150t1" sequenceAccession="LRG_1150t1">
            <Expression>LRG_1150t1:c.1119del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1150p1" sequenceAccession="LRG_1150p1" change="p.Ala374fs">
            <Expression>LRG_1150p1:p.Ala374fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_015559.3(SETBP1):c.1119del (p.Ala374fs) AND Intellectual disability, autosomal dominant 29" Accession="RCV004595086" Version="1">
        <ClassifiedConditionList TraitSetID="19853">
          <ClassifiedCondition DB="MedGen" ID="C4015141">Intellectual disability, autosomal dominant 29</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-16" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-07-23" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25217958</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28346496</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32460883</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="19853" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32123" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 29</ElementValue>
                <XRef Type="MIM" ID="616078" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611060.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611060.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611060.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611060.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611060.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611060.0007" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Intellectual disability, autosomal dominant 29</ElementValue>
                <XRef ID="MONDO:0014482" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MRD29</ElementValue>
                <XRef Type="MIM" ID="616078" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">SETBP1 haploinsufficiency disorder (SETBP1-HD) is characterized by hypotonia and mild motor developmental delay; intellectual abilities ranging from normal to severe disability; speech and language disorder; behavioral problems (most commonly attention/concentration deficits and hyperactivity, impulsivity), and refractive errors and strabismus. Typically children with SETBP1-HD whose intellect is in the normal or borderline range (IQ 80-90) were diagnosed following genetic testing for behavioral problems and/or severe speech and language disorders (respectively: the inability to produce sounds in words correctly, and deficits in the understanding and/or expression of words and sentences). To date, 47 individuals with SETBP1-HD have been reported.</Attribute>
                <XRef ID="NBK575336" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13379" />
                <XRef ID="13379" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">34807554</ID>
                <ID Source="BookShelf">NBK575336</ID>
              </Citation>
              <XRef ID="436151" DB="Orphanet" />
              <XRef ID="C4015141" DB="MedGen" />
              <XRef ID="MONDO:0014482" DB="MONDO" />
              <XRef Type="MIM" ID="616078" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9874283" SubmissionDate="2024-07-18" DateLastUpdated="2024-07-23" DateCreated="2024-07-23">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_015559_3_SETBP1_c_1119delC" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV005087158" DateUpdated="2024-07-23" DateCreated="2024-07-23" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25217958</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28346496</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32460883</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0103 - Loss of function and gain of function are known mechanisms of disease in this gene and are associated with autosomal dominant intellectual developmental disorder 29 (MIM#616078) and Schinzel-Giedion midface retraction syndrome (MIM#269150), respectively. The former is caused by premature termination variants, whereas the latter is caused by missense variants resulting in increased SETBP1 protein stability (PMID: 25217958, 28346496, 32460883). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Other NMD-predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity (ClinVar). These variants have been reported in individuals with an intellectual disability disorder, and are mostly observed as a de novo (GeneReviews). (SP) 0807 - This variant has no previous evidence of pathogenicity. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1206 - This variant has been shown to be paternally inherited (by trio analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SETBP1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_21733</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015559.3:c.1119delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616078" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_45</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9874283" TraitType="Disease" MappingType="XRef" MappingValue="616078" MappingRef="OMIM">
        <MedGen CUI="C4015141" Name="Intellectual disability, autosomal dominant 29" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

